RhumbLine Advisers
BLFS icon

RhumbLine Advisers’s BioLife Solutions BLFS Stock Holding History

RhumbLine Advisers’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Buy
103,975
+9,396
+10% +$220K ﹤0.01% 1744
2026
Q1 		$1.8M Buy
94,579
+1,283
+1% +$28.4K ﹤0.01% 1913
2025
Q4 		$2.26M Buy
93,296
+2,311
+3% +$60.5K ﹤0.01% 1813
2025
Q3 		$2.32M Sell
90,985
-1,923
-2% -$45.6K ﹤0.01% 1831
2025
Q2 		$2M Buy
92,908
+9,681
+12% +$218K ﹤0.01% 1888
2025
Q1 		$1.9M Buy
83,227
+566
+0.7% +$14.9K ﹤0.01% 1829
2024
Q4 		$2.15M Sell
82,661
-357
-0.4% -$8.88K ﹤0.01% 1847
2024
Q3 		$2.08M Sell
83,018
-4,455
-5% -$105K ﹤0.01% 1892
2024
Q2 		$1.87M Buy
87,473
+3,912
+5% +$75.9K ﹤0.01% 1919
2024
Q1 		$1.55M Buy
83,561
+987
+1% +$17.3K ﹤0.01% 2031
2023
Q4 		$1.34M Buy
82,574
+2,207
+3% +$28.2K ﹤0.01% 2115
2023
Q3 		$1.11M Buy
80,367
+116
+0.1% +$1.83K ﹤0.01% 2146
2023
Q2 		$1.77M Sell
80,251
-7,097
-8% -$149K ﹤0.01% 1978
2023
Q1 		$1.9M Buy
87,348
+4,717
+6% +$106K ﹤0.01% 1832
2022
Q4 		$1.5M Buy
82,631
+4,039
+5% +$83.4K ﹤0.01% 1936
2022
Q3 		$1.79M Buy
78,592
+6,480
+9% +$139K ﹤0.01% 1822
2022
Q2 		$996K Buy
72,112
+35,914
+99% +$527K ﹤0.01% 2147
2022
Q1 		$823K Sell
36,198
-15,874
-30% -$418K ﹤0.01% 2210
2021
Q4 		$1.94M Sell
52,072
-7,722
-13% -$331K ﹤0.01% 1902
2021
Q3 		$2.53M Buy
59,794
+36,767
+160% +$1.77M ﹤0.01% 1763
2021
Q2 		$1.02M Buy
23,027
+9,055
+65% +$319K ﹤0.01% 2237
2021
Q1 		$503K Buy
13,972
+335
+2% +$13.2K ﹤0.01% 2491
2020
Q4 		$544K Buy
13,637
+2,525
+23% +$86.1K ﹤0.01% 2407
2020
Q3 		$322K Buy
+11,112
New +$240K ﹤0.01% 2483

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RhumbLine Advisers's BLFS Position: Q2 2026 in Review

RhumbLine Advisers increased its BioLife Solutions (BLFS) stake by 9.9% in Q2 2026, buying an estimated $220K and bringing the position to 103,975 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

RhumbLine Advisers first reported a position in BLFS in Q3 2020 and has held it in 24 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • RhumbLine Advisers held 103,975 shares of BioLife Solutions worth $2.94M as of Q2 2026.
  • RhumbLine Advisers bought 9,396 BioLife Solutions shares in Q2 2026, an estimated $220K.
  • BioLife Solutions made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1744 holding.
  • RhumbLine Advisers first reported a position in BioLife Solutions in Q3 2020 and has held it in 24 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.